FTC Solar, Inc. FTCI Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0000950170-25-061469
cik 1828161
name FTC SOLAR, INC.
sic 3674
countryba US
stprba TX
cityba AUSTIN
zipba 78759
bas1 9020 N CAPITAL OF TEXAS HWY, SUITE I-260
bas2
baph (907) 312-0717
countryma US
stprma TX
cityma AUSTIN
zipma 78759
mas1 9020 N CAPITAL OF TEXAS HWY, SUITE I-260
mas2
countryinc US
stprinc DE
ein 814816270
former
changed
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250501
accepted 2025-05-01 09:16:00.0
prevrpt 0
detail 1
instance ftci-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0000950170-25-061469 20241231 Accounts And Financing Receivable Allowance For Credit Loss 1717000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Accounts Payable Current 12995000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Accrued Liabilities Current 20134000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Additional Paid In Capital 367601000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Cash Paid During The Period For Third Party Interest 140000.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Common Stock Value 1000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Cost Of Goods And Services Sold 2328000.0000 USD 1 us-gaap/2024 Product Or Service= Service;
0000950170-25-061469 20250331 Cost Of Goods And Services Sold 24250000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Cost Of Goods And Services Sold 4139000.0000 USD 1 us-gaap/2024 Product Or Service= Service;
0000950170-25-061469 20240331 Depreciation And Amortization 404000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Increase Decrease In Accounts Receivable 1770000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Increase Decrease In Other Operating Assets 216000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Increase Decrease In Other Operating Capital Net 287000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Inventory Net 10144000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Liabilities Current 49073000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Long Term Debt 9466000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Net Cash Provided By Used In Operating Activities -8483000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Payments To Acquire Property Plant And Equipment 432000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Prepaid Expense And Other Assets Current 15028000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Proceeds From Sale Of Equity Method Investments 3204000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Proceeds From Sale Of Property Plant And Equipment 3000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Product Warranty Expense 838000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Property Plant And Equipment Net 2217000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Property Plant And Equipment Net 2217000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Property Plant And Equipment Net 1951000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Purchase Of Property And Equipment Included In Account Payable 4000.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20231231 Stockholders Equity -299135000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-061469 20240331 Stockholders Equity -307906000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-061469 20241231 Stockholders Equity 19036000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Stockholders Equity -542000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-061469 20241231 Stockholders Equity 367318000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-061469 20250331 Stockholders Equity -514000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-061469 20250331 Stock Issued During Period Shares Restricted Stock Award Gross 209486.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-061469 20241231 Warrant Liability 9520000.0000 USD 0 0000950170-25-061469
0000950170-25-061469 20250331 Warrant Liability 4916000.0000 USD 0 0000950170-25-061469
0000950170-25-061469 20250331 Gross Profit -3447000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Accrued Liabilities Current 23245000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -514000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Cash And Cash Equivalents At Carrying Value 5909000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Common Stock Shares Issued 12853823.0000 shares 0 us-gaap/2024
0000950170-25-061469 20250331 Deferred Income Tax Expense Benefit 426000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Depreciation And Amortization 302000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Earnings Per Share Basic -0.3000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Gain Loss On Sale Of Property Plant Equipment 0.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 General And Administrative Expense 5053000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -8782000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Income Taxes Paid 58000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Income Tax Expense Benefit 254000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Increase Decrease In Other Accounts Payable And Accrued Liabilities -6200000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Increase Decrease In Other Accounts Payable And Accrued Liabilities 2539000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Interest Expense 317000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Interest Expense 711000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Interest Income Operating 181000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Inventory Net 6828000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Liabilities 70892000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Net Cash Provided By Used In Investing Activities 3124000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Operating Lease Liability Noncurrent 344000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 5909000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250228 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024 Longterm Debt Type= Term Sheet; Subsidiary Sale Of Stock= Private Placement;
0000950170-25-061469 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Common Stock Value 1000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Cost Of Goods And Services Sold 20111000.0000 USD 1 us-gaap/2024 Product Or Service= Product;
0000950170-25-061469 20240331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -59000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 General And Administrative Expense 6567000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Income Taxes Paid 7000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Increase Decrease In Other Noncurrent Liabilities -415000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Liabilities And Stockholders Equity 89928000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Net Cash Provided By Used In Investing Activities 2618000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal 670000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Operating Lease Right Of Use Asset 1149000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 28000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Other Liabilities Current 10313000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Paid In Kind Non Cash Interest Added To Senior Notes Principal 0.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20240331 Proceeds From Sale Of Equity Method Investments 4085000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Proceeds From Stock Options Exercised 0.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Shares Outstanding 1076257.0000 shares 0 us-gaap/2024 Equity Components= Treasury Stock1;
0000950170-25-061469 20231231 Stockholders Equity 62471000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Stockholders Equity 55158000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock1;
0000950170-25-061469 20250331 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-061469 20250331 Stock Issued During Period Shares Stock Options Exercised 5000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-061469 20241231 Taxes Payable Current 325000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Treasury Stock Common Shares 1076257.0000 shares 0 us-gaap/2024
0000950170-25-061469 20250331 Warrants Recoverable From Manufacturer -80000.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20240331 Weighted Average Number Of Diluted Shares Outstanding 12556938.0000 shares 1 us-gaap/2024
0000950170-25-061469 20250331 Other Comprehensive Income Loss Net Of Tax 28000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Other Noncash Income Expense -309000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Other Nonoperating Income Expense 4000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Payments To Acquire Property Plant And Equipment 83000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Retained Earnings Accumulated Deficit -351560000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Share Based Compensation 280000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Shares Outstanding 12853823.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-061469 20240331 Stockholders Equity 363537000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-061469 20240331 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0000950170-25-061469 20250331 Stockholders Equity 15528000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Accounts And Financing Receivable Allowance For Credit Loss 1625000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Accounts Payable Current 1200000.0000 USD 0 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Alpha Steel;
0000950170-25-061469 20250331 Accounts Receivable Net Current 44238000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -542000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Additional Paid In Capital 367318000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Assets 84061000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -9298000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Cost Of Goods And Services Sold 14695000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Earnings Per Share Diluted -0.7000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Equity Method Investment Realized Gain Loss On Disposal 3204000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Goodwill 7213000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets -918000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal -92000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Operating Lease Liability Noncurrent 411000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Operating Lease Right Of Use Asset 959000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Other Comprehensive Income Loss Net Of Tax 28000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-061469 20241231 Other Liabilities Noncurrent 2422000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Payments To Acquire Other Investments 1035000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1639000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1639000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-061469 20250331 Amortization Of Financing Costs 210000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Assets 89928000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Cash And Cash Equivalents At Carrying Value 14041000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 25235000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 15937000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Interest Income Operating 6000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Liabilities 68533000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -5338000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Earnings Per Share Basic -0.7000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Equity Method Investments 842000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Fair Value Adjustment Of Warrants 0.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Increase Decrease In Deferred Revenue -3069000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Increase Decrease In Other Operating Assets 226000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Net Cash Provided By Used In Financing Activities 3000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Net Cash Provided By Used In Operating Activities -11857000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Net Income Loss -8771000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-061469 20250331 Net Income Loss -3819000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Operating Expenses 10394000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Operating Expenses 7113000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Other Comprehensive Income Loss Net Of Tax -181000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Other Liabilities Current 10373000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Other Noncash Income Expense -327000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Other Nonoperating Income Expense 36000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Provision For Inventory Obsolescence 0.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20240331 Purchase Of Property And Equipment Included In Account Payable 175000.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20250331 Research And Development Expense 924000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Revenue From Contract With Customer Excluding Assessed Tax 12587000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Selling And Marketing Expense 1136000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20231231 Shares Outstanding 0.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0000950170-25-061469 20240331 Shares Outstanding 1076257.0000 shares 0 us-gaap/2024 Equity Components= Treasury Stock1;
0000950170-25-061469 20231231 Stockholders Equity -293000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-061469 20231231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock1;
0000950170-25-061469 20241231 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-061469 20250331 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock1;
0000950170-25-061469 20250331 Taxes Payable Current 407000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Weighted Average Number Of Shares Outstanding Basic 12556938.0000 shares 1 us-gaap/2024
0000950170-25-061469 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-061469 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Proceeds From Sale Of Property Plant And Equipment 0.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Revenue From Contract With Customer Excluding Assessed Tax 1682000.0000 USD 1 us-gaap/2024 Product Or Service= Service;
0000950170-25-061469 20240331 Shares Outstanding 0.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0000950170-25-061469 20231231 Stockholders Equity 361898000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-061469 20231231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0000950170-25-061469 20241231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0000950170-25-061469 20241231 Stockholders Equity -347741000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-061469 20250331 Stockholders Equity 367601000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-061469 20241231 Treasury Stock Value 0.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Warrants Recoverable From Manufacturer -98000.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20231231 Accounts And Financing Receivable Allowance For Credit Loss 8557000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Accounts And Financing Receivable Allowance For Credit Loss 9227000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Accounts Payable Current 500000.0000 USD 0 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Alpha Steel;
0000950170-25-061469 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 280000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 280000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-061469 20240331 Amortization Of Financing Costs 177000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Assets Current 76128000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Cash Paid During The Period For Third Party Interest 8000.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-061469 20250331 Common Stock Shares Outstanding 13068309.0000 shares 0 us-gaap/2024
0000950170-25-061469 20240331 Cost Of Goods And Services Sold 12367000.0000 USD 1 us-gaap/2024 Product Or Service= Product;
0000950170-25-061469 20250331 Fair Value Adjustment Of Warrants -4604000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Gain Loss On Sale Of Property Plant Equipment 3000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20231231 Goodwill 7538000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Goodwill 7139000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Gross Profit -2108000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -3565000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Increase Decrease In Accounts Payable 3989000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Increase Decrease In Accounts Payable 1688000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Increase Decrease In Other Noncurrent Liabilities -523000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Net Income Loss -8771000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Operating Income Loss -12502000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Operating Income Loss -10560000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Other Assets Noncurrent 2038000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Other Comprehensive Income Loss Net Of Tax -181000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-061469 20240331 Paid In Kind Interest 0.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Paid In Kind Interest 492000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Paid In Kind Non Cash Interest Added To Senior Notes Principal 492000.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20241231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-061469 20250331 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Proceeds From Stock Options Exercised 3000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Restricted Cash 1896000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Restricted Cash 0.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Retained Earnings Accumulated Deficit -347741000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Revenue From Contract With Customer Excluding Assessed Tax 18202000.0000 USD 1 us-gaap/2024 Product Or Service= Product;
0000950170-25-061469 20250331 Revenue From Contract With Customer Excluding Assessed Tax 2601000.0000 USD 1 us-gaap/2024 Product Or Service= Service;
0000950170-25-061469 20240331 Share Based Compensation 1639000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Shares Outstanding 0.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0000950170-25-061469 20240331 Stockholders Equity -474000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-061469 20240331 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock; * -Prior year shares and amounts, as applicable, have been revised to reflect the Reverse Stock Split effective November 29, 2024.
0000950170-25-061469 20250331 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0000950170-25-061469 20250331 Stockholders Equity -351560000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-061469 20240331 Stock Issued During Period Shares Restricted Stock Award Gross 50693.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-061469 20250331 Stock Issued During Period Value Stock Options Exercised 3000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Stock Issued During Period Value Stock Options Exercised 3000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-061469 20250331 Treasury Stock Value 0.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Weighted Average Number Of Diluted Shares Outstanding 14588972.0000 shares 1 us-gaap/2024
0000950170-25-061469 20240331 Assets 115030000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Assets Current 71098000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Common Stock Shares Authorized 850000000.0000 shares 0 us-gaap/2024
0000950170-25-061469 20250331 Common Stock Shares Issued 13068309.0000 shares 0 us-gaap/2024
0000950170-25-061469 20240331 Comprehensive Income Net Of Tax -8952000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Contract With Customer Liability Current 5306000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Contract With Customer Liability Current 2237000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Deferred Income Tax Expense Benefit 225000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 18000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Equity Method Investment Realized Gain Loss On Disposal 4085000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Equity Method Investments 954000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Goodwill 7173000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Income Loss From Equity Method Investments Net Of Dividends Or Distributions -112000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Increase Decrease In Accounts Receivable 4437000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Increase Decrease In Inventories 116000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Increase Decrease In Inventories -3316000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Liabilities And Stockholders Equity 84061000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Net Cash Provided By Used In Financing Activities 0.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Net Income Loss -3819000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-061469 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -181000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Paid In Kind Interest 600000.0000 USD 1 us-gaap/2024 Longterm Debt Type= Senior Notes;
0000950170-25-061469 20250331 Payments To Acquire Other Investments 0.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Preferred Stock Shares Authorized 10000000.0000 shares 0 us-gaap/2024
0000950170-25-061469 20250331 Prepaid Expense And Other Assets Current 14123000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20240331 Provision For Inventory Obsolescence 177000.0000 USD 1 0000950170-25-061469
0000950170-25-061469 20240331 Research And Development Expense 1439000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Revenue From Contract With Customer Excluding Assessed Tax 10905000.0000 USD 1 us-gaap/2024 Product Or Service= Product;
0000950170-25-061469 20240331 Selling And Marketing Expense 2388000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20231231 Shares Outstanding 12544533.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-061469 20231231 Shares Outstanding 1076257.0000 shares 0 us-gaap/2024 Equity Components= Treasury Stock1;
0000950170-25-061469 20240331 Shares Outstanding 12595226.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-061469 20250331 Shares Outstanding 1076257.0000 shares 0 us-gaap/2024 Equity Components= Treasury Stock1;
0000950170-25-061469 20240331 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock1;
0000950170-25-061469 20250331 Treasury Stock Common Shares 1076257.0000 shares 0 us-gaap/2024
0000950170-25-061469 20250331 Weighted Average Number Of Shares Outstanding Basic 12888695.0000 shares 1 us-gaap/2024
0000950170-25-061469 20250331 Accounts Payable Current 14636000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Accounts Receivable Net Current 39709000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Cash And Cash Equivalents At Carrying Value 11247000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 11247000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-061469 20241231 Common Stock Shares Authorized 850000000.0000 shares 0 us-gaap/2024
0000950170-25-061469 20241231 Common Stock Shares Outstanding 12853823.0000 shares 0 us-gaap/2024
0000950170-25-061469 20250331 Comprehensive Income Net Of Tax -3791000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Earnings Per Share Diluted -0.5800 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Income Loss From Equity Method Investments Net Of Dividends Or Distributions -265000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Income Tax Expense Benefit -11000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Increase Decrease In Deferred Revenue 1285000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Increase Decrease In Other Operating Capital Net 359000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -45000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Liabilities Current 50898000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Long Term Debt 10169000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Other Assets Noncurrent 2341000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20250331 Other Liabilities Noncurrent 2206000.0000 USD 0 us-gaap/2024
0000950170-25-061469 20241231 Preferred Stock Shares Authorized 10000000.0000 shares 0 us-gaap/2024
0000950170-25-061469 20250331 Product Warranty Expense 1045000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20250331 Revenue From Contract With Customer Excluding Assessed Tax 20803000.0000 USD 1 us-gaap/2024
0000950170-25-061469 20241231 Shares Outstanding 0.0000 shares 0 us-gaap/2024 Equity Components= Preferred Stock;
0000950170-25-061469 20250331 Shares Outstanding 13068309.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-061469 20231231 Stockholders Equity 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Stock Issued During Period Value Stock Options Exercised us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Warrant Liability 0000950170-25-061469 1 0 monetary I C Warrant liability Warrant liability
Income Loss From Equity Method Investments Net Of Dividends Or Distributions us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments, Net of Dividends or Distributions This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Depreciation And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization, Nonproduction The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
Taxes Payable Current us-gaap/2024 0 0 monetary I C Taxes Payable, Current Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Paid In Kind Non Cash Interest Added To Senior Notes Principal 0000950170-25-061469 1 0 monetary D D Paid In Kind Non Cash Interest Added To Senior Notes principal Paid In Kind Non Cash Interest Added To Senior Notes principal
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Proceeds From Stock Options Exercised us-gaap/2024 0 0 monetary D D Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Product Warranty Expense us-gaap/2024 0 0 monetary D D Product Warranty Expense The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Treasury Stock Value us-gaap/2024 0 0 monetary I D Treasury Stock, Value The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Cost Of Goods And Services Sold us-gaap/2024 0 0 monetary D D Cost of Goods and Services Sold The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Income Taxes Paid us-gaap/2024 0 0 monetary D C Income Taxes Paid Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Interest Expense us-gaap/2024 0 0 monetary D D Interest Expense, Operating and Nonoperating Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.
Long Term Debt us-gaap/2024 0 0 monetary I C Long-Term Debt Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Selling And Marketing Expense us-gaap/2024 0 0 monetary D D Selling and Marketing Expense The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Cash Paid During The Period For Third Party Interest 0000950170-25-061469 1 0 monetary D C Cash paid during the period for third party interest Cash paid during the period for third party interest
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Increase Decrease In Other Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.
Increase Decrease In Other Operating Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other.
Increase Decrease In Other Operating Capital Net us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Operating Assets and Liabilities, Net Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.
Payments To Acquire Other Investments us-gaap/2024 0 0 monetary D C Payments to Acquire Other Investments Amount of cash outflow to acquire investments classified as other.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Paid In Kind Interest us-gaap/2024 0 0 monetary D D Paid-in-Kind Interest Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Deferred Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Equity Method Investment Realized Gain Loss On Disposal us-gaap/2024 0 0 monetary D C Equity Method Investment, Realized Gain (Loss) on Disposal Amount of gain (loss) on sale or disposal of an equity method investment.
Equity Method Investments us-gaap/2024 0 0 monetary I D Equity Method Investments This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Interest Income Operating us-gaap/2024 0 0 monetary D C Interest Income, Operating Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.
Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Other Liabilities Current us-gaap/2024 0 0 monetary I C Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
Other Noncash Income Expense us-gaap/2024 0 0 monetary D C Other Noncash Income (Expense) Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 0 0 monetary D D Proceeds from Sale of Property, Plant, and Equipment The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Purchase Of Property And Equipment Included In Account Payable 0000950170-25-061469 1 0 monetary D C Purchase Of Property And Equipment Included In Account Payable Purchase of property and equipment included in account payable.
Goodwill us-gaap/2024 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Other Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Restricted Cash us-gaap/2024 0 0 monetary I D Restricted Cash Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Provision For Inventory Obsolescence 0000950170-25-061469 1 0 monetary D D Provision For Inventory Obsolescence Expense charge to establish an inventory obsolesce reserve.
Warrants Recoverable From Manufacturer 0000950170-25-061469 1 0 monetary D C Warrants Recoverable From Manufacturer Warrants recoverable from manufacturer.
Amortization Of Financing Costs us-gaap/2024 0 0 monetary D D Amortization of Debt Issuance Costs Amount of amortization expense attributable to debt issuance costs.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal us-gaap/2024 0 0 monetary D D Off-Balance-Sheet, Credit Loss, Liability, Credit Loss Expense (Reversal) Amount of expense (reversal of expense) for expected credit loss for off-balance sheet credit exposure. Excludes off-balance sheet credit exposure accounted for as insurance and instrument accounted for under derivatives and hedging.
Proceeds From Sale Of Equity Method Investments us-gaap/2024 0 0 monetary D D Proceeds from Sale of Equity Method Investments The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Fair Value Adjustment Of Warrants us-gaap/2024 0 0 monetary D D Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability.
Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Property Plant Equipment Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Accounts And Financing Receivable Allowance For Credit Loss us-gaap/2024 0 0 monetary I C Accounts and Financing Receivable, Allowance for Credit Loss Amount of allowance for credit loss of accounts and financing receivables. Includes, but is not limited to, notes and loan receivable.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Contract With Customer Liability Current us-gaap/2024 0 0 monetary I C Contract with Customer, Liability, Current Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Increase Decrease In Deferred Revenue us-gaap/2024 0 0 monetary D D Increase (Decrease) in Deferred Revenue Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.
Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Noncurrent Liabilities Amount of increase (decrease) in noncurrent operating liabilities classified as other.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Treasury Stock Common Shares us-gaap/2024 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0000950170-25-061469 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000950170-25-061469 2 4 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net of allowance for credit losses of $1,625 and $1,717 at March 31,2025 and December 31, 2024, respectively 0
0000950170-25-061469 2 5 BS 0 H Inventory Net us-gaap/2024 Inventories 0
0000950170-25-061469 2 6 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid and other current assets 0
0000950170-25-061469 2 7 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0000950170-25-061469 2 8 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use assets 0
0000950170-25-061469 2 9 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0000950170-25-061469 2 10 BS 0 H Goodwill us-gaap/2024 Goodwill 0
0000950170-25-061469 2 11 BS 0 H Equity Method Investments us-gaap/2024 Equity method investment 0
0000950170-25-061469 2 12 BS 0 H Other Assets Noncurrent us-gaap/2024 Other assets 0
0000950170-25-061469 2 13 BS 0 H Assets us-gaap/2024 Total assets 0
0000950170-25-061469 2 16 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0000950170-25-061469 2 17 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued expenses 0
0000950170-25-061469 2 18 BS 0 H Taxes Payable Current us-gaap/2024 Income taxes payable 0
0000950170-25-061469 2 19 BS 0 H Contract With Customer Liability Current us-gaap/2024 Deferred revenue 0
0000950170-25-061469 2 20 BS 0 H Other Liabilities Current us-gaap/2024 Other current liabilities 0
0000950170-25-061469 2 21 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0000950170-25-061469 2 22 BS 0 H Long Term Debt us-gaap/2024 Long-term debt 0
0000950170-25-061469 2 23 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liability, net of current portion 0
0000950170-25-061469 2 24 BS 0 H Warrant Liability 0000950170-25-061469 Warrant liability 0
0000950170-25-061469 2 25 BS 0 H Other Liabilities Noncurrent us-gaap/2024 Other non-current liabilities 0
0000950170-25-061469 2 26 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0000950170-25-061469 2 27 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Note 13) 0
0000950170-25-061469 2 29 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock par value of $0.0001 per share, 10,000,000 shares authorized; none issued as of March 31, 2025 and December 31, 2024 0
0000950170-25-061469 2 30 BS 0 H Common Stock Value us-gaap/2024 Common stock par value of $0.0001 per share, 850,000,000 shares authorized; 13,068,309 and 12,853,823 shares issued and outstanding as of March 31, 2025 and December 31, 2024 0
0000950170-25-061469 2 31 BS 0 H Treasury Stock Value us-gaap/2024 Treasury stock, at cost; 1,076,257 shares as of March 31, 2025 and December 31, 2024 1
0000950170-25-061469 2 32 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0000950170-25-061469 2 33 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive loss 0
0000950170-25-061469 2 34 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0000950170-25-061469 2 35 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders' equity 0
0000950170-25-061469 2 36 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' equity 0
0000950170-25-061469 3 1 BS 1 H Accounts And Financing Receivable Allowance For Credit Loss us-gaap/2024 Allowance for credit losses 0
0000950170-25-061469 3 2 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value 0
0000950170-25-061469 3 3 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized 0
0000950170-25-061469 3 4 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued 0
0000950170-25-061469 3 5 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0000950170-25-061469 3 6 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0000950170-25-061469 3 7 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0000950170-25-061469 3 8 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0000950170-25-061469 3 9 BS 1 H Treasury Stock Common Shares us-gaap/2024 Treasury Stock, Shares 0
0000950170-25-061469 4 8 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Total revenue 0
0000950170-25-061469 4 10 IS 0 H Cost Of Goods And Services Sold us-gaap/2024 Total cost of revenue 0
0000950170-25-061469 4 11 IS 0 H Gross Profit us-gaap/2024 Gross profit (loss) 0
0000950170-25-061469 4 13 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0000950170-25-061469 4 14 IS 0 H Selling And Marketing Expense us-gaap/2024 Selling and marketing 0
0000950170-25-061469 4 15 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0000950170-25-061469 4 16 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0000950170-25-061469 4 17 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0000950170-25-061469 4 18 IS 0 H Interest Expense us-gaap/2024 Interest expense 1
0000950170-25-061469 4 19 IS 0 H Interest Income Operating us-gaap/2024 Interest income 0
0000950170-25-061469 4 20 IS 0 H Equity Method Investment Realized Gain Loss On Disposal us-gaap/2024 Gain from disposal of investment in unconsolidated subsidiary 0
0000950170-25-061469 4 21 IS 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Gain from change in fair value of warrant liability 1
0000950170-25-061469 4 22 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income, net 0
0000950170-25-061469 4 23 IS 0 H Income Loss From Equity Method Investments Net Of Dividends Or Distributions us-gaap/2024 Loss from unconsolidated subsidiary 0
0000950170-25-061469 4 24 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Loss before income taxes 0
0000950170-25-061469 4 25 IS 0 H Income Tax Expense Benefit us-gaap/2024 (Provision for) benefit from income taxes 1
0000950170-25-061469 4 26 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-061469 4 28 IS 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustments 0
0000950170-25-061469 4 29 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive loss 0
0000950170-25-061469 4 31 IS 0 H Earnings Per Share Basic us-gaap/2024 Basic 0
0000950170-25-061469 4 32 IS 0 H Earnings Per Share Diluted us-gaap/2024 Diluted 0
0000950170-25-061469 4 34 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Basic 0
0000950170-25-061469 4 35 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Diluted 0
0000950170-25-061469 5 13 EQ 0 H Stockholders Equity us-gaap/2024 Beginning balance 0
0000950170-25-061469 5 14 EQ 0 H Shares Outstanding us-gaap/2024 Beginning balance (in shares) 0
0000950170-25-061469 5 15 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 Shares issued during the period for vested restricted stock awards, shares 0
0000950170-25-061469 5 16 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2024 Issuance of common stock upon exercise of stock options 0
0000950170-25-061469 5 17 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 Issuance of common stock upon exercise of stock options, shares 0
0000950170-25-061469 5 19 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation 0
0000950170-25-061469 5 20 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-061469 5 21 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive gain (loss) 0
0000950170-25-061469 5 22 EQ 0 H Stockholders Equity us-gaap/2024 Ending balance 0
0000950170-25-061469 5 23 EQ 0 H Shares Outstanding us-gaap/2024 Ending balance (in shares) 0
0000950170-25-061469 6 2 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0000950170-25-061469 6 4 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation 0
0000950170-25-061469 6 5 CF 0 H Depreciation And Amortization us-gaap/2024 Depreciation and amortization 0
0000950170-25-061469 6 6 CF 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Gain from change in fair value of warrant liability 0
0000950170-25-061469 6 7 CF 0 H Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 Gain from sale of property and equipment 1
0000950170-25-061469 6 8 CF 0 H Amortization Of Financing Costs us-gaap/2024 Amortization of debt discount and issue costs 0
0000950170-25-061469 6 9 CF 0 H Paid In Kind Interest us-gaap/2024 Paid-in-kind non-cash interest 0
0000950170-25-061469 6 10 CF 0 H Provision For Inventory Obsolescence 0000950170-25-061469 Provision for obsolete and slow-moving inventory 0
0000950170-25-061469 6 11 CF 0 H Income Loss From Equity Method Investments Net Of Dividends Or Distributions us-gaap/2024 Loss from unconsolidated subsidiary 1
0000950170-25-061469 6 12 CF 0 H Equity Method Investment Realized Gain Loss On Disposal us-gaap/2024 Gain from disposal of investment in unconsolidated subsidiary 1
0000950170-25-061469 6 13 CF 0 H Product Warranty Expense us-gaap/2024 Warranties issued and remediation added 0
0000950170-25-061469 6 14 CF 0 H Warrants Recoverable From Manufacturer 0000950170-25-061469 Warranty recoverable from manufacturer 1
0000950170-25-061469 6 15 CF 0 H Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal us-gaap/2024 Credit loss (credits) provisions 0
0000950170-25-061469 6 16 CF 0 H Deferred Income Tax Expense Benefit us-gaap/2024 Deferred income taxes 0
0000950170-25-061469 6 17 CF 0 H Other Noncash Income Expense us-gaap/2024 Lease expense and other 1
0000950170-25-061469 6 19 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable 1
0000950170-25-061469 6 20 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories 1
0000950170-25-061469 6 21 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid and other current assets 1
0000950170-25-061469 6 22 CF 0 H Increase Decrease In Other Operating Assets us-gaap/2024 Other assets 1
0000950170-25-061469 6 23 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0000950170-25-061469 6 24 CF 0 H Increase Decrease In Other Accounts Payable And Accrued Liabilities us-gaap/2024 Accruals and other current liabilities 0
0000950170-25-061469 6 25 CF 0 H Increase Decrease In Deferred Revenue us-gaap/2024 Deferred revenue 0
0000950170-25-061469 6 26 CF 0 H Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 Other non-current liabilities 0
0000950170-25-061469 6 27 CF 0 H Increase Decrease In Other Operating Capital Net us-gaap/2024 Lease payments and other, net 1
0000950170-25-061469 6 28 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operations 0
0000950170-25-061469 6 30 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property and equipment 1
0000950170-25-061469 6 31 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Proceeds from sale of property and equipment 0
0000950170-25-061469 6 32 CF 0 H Payments To Acquire Other Investments us-gaap/2024 Equity method investment in Alpha Steel 1
0000950170-25-061469 6 33 CF 0 H Proceeds From Sale Of Equity Method Investments us-gaap/2024 Proceeds from disposal of investment in unconsolidated subsidiary 0
0000950170-25-061469 6 34 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash provided by (used in) investing activities 0
0000950170-25-061469 6 36 CF 0 H Proceeds From Stock Options Exercised us-gaap/2024 Proceeds from stock option exercises 0
0000950170-25-061469 6 37 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0000950170-25-061469 6 38 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of exchange rate changes on cash, cash equivalents and restricted cash 0
0000950170-25-061469 6 39 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Decrease in cash, cash equivalents and restricted cash 0
0000950170-25-061469 6 40 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0000950170-25-061469 6 41 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0000950170-25-061469 6 43 CF 0 H Purchase Of Property And Equipment Included In Account Payable 0000950170-25-061469 Purchases of property and equipment included in ending accounts payable and accruals 0
0000950170-25-061469 6 44 CF 0 H Paid In Kind Non Cash Interest Added To Senior Notes Principal 0000950170-25-061469 Paid-in-kind non-cash interest added to Senior Notes principal 0
0000950170-25-061469 6 45 CF 0 H Cash Paid During The Period For Third Party Interest 0000950170-25-061469 Cash paid during the period for interest 0
0000950170-25-061469 6 46 CF 0 H Income Taxes Paid us-gaap/2024 Cash paid during the period for taxes, net of refunds 0
0000950170-25-061469 6 48 CF 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000950170-25-061469 6 49 CF 0 H Restricted Cash us-gaap/2024 Restricted cash 0
0000950170-25-061469 6 50 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Total cash, cash equivalents and restricted cash 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.